Reviva Pharmaceuticals Holdings, Inc. (RVPH) Social Stream
REVIVA PHARMACEUTICALS HOLDINGS INC (RVPH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering REVIVA PHARMACEUTICALS HOLDINGS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-24 | 1 | $19 | $10 | $14.5 | $5.15 | 181.55% |
| 2022-01-11 | 1 | $16 | $10 | $13 | $5.15 | 152.43% |
| 2022-03-17 | 2 | $16 | $10 | $12 | $5.15 | 133.01% |
| 2022-05-19 | 2 | $16 | $5 | $10.333 | $5.15 | 100.64% |
| 2022-08-19 | 1 | $16 | $5 | $10.333 | $5.15 | 100.64% |
| 2022-11-18 | 2 | $16 | $10 | $14 | $5.15 | 171.84% |
| 2023-04-04 | 2 | $16 | $10 | $13 | $5.15 | 152.43% |
| 2023-06-02 | 2 | $18 | $10 | $15 | $5.15 | 191.26% |
| 2023-08-18 | 3 | $18 | $10 | $15.4 | $5.15 | 199.03% |
| 2023-09-25 | 4 | $18 | $10 | $14.833 | $5.15 | 188.02% |
| 2023-10-31 | 4 | $20 | $12 | $16.6 | $5.15 | 222.33% |
| 2023-11-20 | 4 | $20 | $12 | $17 | $5.15 | 230.1% |
The Trend in the Analyst Price Target
RVPH's average price target has moved up $3.25 over the prior 28 weeks.
Over the past 43 weeks, RVPH's average upside potential has been 220.23%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-08 | 2 | 18 | 10 | 15.000 | 8.36 | 79.43% |
| 2023-08-16 | 3 | 18 | 10 | 15.400 | 4.00 | 285% |
| 2023-09-20 | 4 | 18 | 10 | 14.833 | 5.01 | 196.07% |
| 2023-10-31 | 4 | 20 | 12 | 16.600 | 4.69 | 253.94% |
| 2023-11-20 | 3 | 20 | 12 | 17.000 | 4.21 | 303.8% |
RVPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
RVPH's average broker recommendation rating improved by 0 over the prior 153 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how REVIVA PHARMACEUTICALS HOLDINGS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 98.49% of that group.
- RVPH has a greater upside potential (average analyst target price relative to current price) than 1372.75% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, REVIVA PHARMACEUTICALS HOLDINGS INC's average analyst price target is higher than 267.2% of them.
- RVPH has a lower variance in analysts' estimates than -1041.51% of stocks in the micro market cap category.
Stocks similar to REVIVA PHARMACEUTICALS HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ADIL, GNPX, and ALRN.
View All Top Stocks by Price Target
Make investment decisions regarding RVPH using the data that counts. Try POWR Ratings for free.